Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $146 | In Stock | |
2 mg | $198 | In Stock | |
5 mg | $308 | In Stock | |
10 mg | $443 | In Stock | |
25 mg | $732 | In Stock | |
50 mg | $987 | In Stock | |
100 mg | $1,390 | In Stock | |
1 mL x 10 mM (in DMSO) | $323 | In Stock |
Description | CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin. |
Targets&IC50 | CDK6:37.68 nM, CDK2:3.27 nM, CDK9:5.78 nM, CDK4:8.18 nM, CDK7:134.26 nM, CDK1:8.17 nM |
In vitro | CDKI-73, one of the most potent CDK9 inhibitors, against a panel of AML cell lines and samples derived from 97 patients.?CDKI-73 induced cancer cells undergoing apoptosis through transcriptional downregulation of anti-apoptotic proteins Bcl-2, Mcl-1 and XIAP by majorly targeting CDK9[3]. |
In vivo | CDKI-73 exhibited a favorable pharmacokinetic profile with oral bioavailability of F = 56% following a single intravenous bolus dose at 2 mg/kg and an oral dose at 10 mg/kg in mice [1]. |
Molecular Weight | 394.45 |
Formula | C15H15FN6O2S2 |
Cas No. | 1421693-22-2 |
Smiles | CNc1nc(C)c(s1)-c1nc(Nc2cccc(c2)S(N)(=O)=O)ncc1F |
Relative Density. | 1.524 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 52 mg/mL (131.83 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.